For many years, the Nuclear Regulatory Commission in the United States required
hospitalization for purposes of radiation isolation of patients receiving 1.11 GBq (30 mCi) or …

Historically, nuclear medicine has been largely a diagnostic specialty, utilizing relatively low
administered activities to obtain important diagnostic information whose benefits far …

Medical licenses issued by the Nuclear Regulatory Commission contain the restriction that
patients who are being treated with 131I should not be discharged from the hospital if the …

toxicosis in 262 children 3 to 18 yr of age treated for hyperthyroidism from 1947 to 1984.
Ofthe 239 whose treat ment was complete, 91 (38%) ulti mately had â€@ †Itreatment …

Following a therapeutic administration of iodine-131 the patient becomes a potential
radiation hazard to other individuals: firstly, radiation is emitted from radioactivity in the …

Recently, there has been a Congressional examination of the safety to the public when
outpatients are treated with I-131. The regulations regarding this procedure are being …

Awidely accepted therapy is 131I for patients with hyperthyroidism caused by Graves'
disease, toxic nodular disease, euthyroid multinodular goiters, and differentiated thyroid …

Many patients treated with 131I, mainly for thyroid cancer, have been subjected to inpatient
isolation for no medical reason. Protection of the environment from a radioactive source …

A Manual of Good Practice has been prepared by a Panel of the British Radiological
Protection Association, concerned with the radiation protection of patients undergoing …

Patients receiving 131 I-based therapies are generally restricted in leaving the medical
institution. In the US, the US Nuclear Regulatory Commission (US NRC) has developed the …